Effect of Age and Gender on the PK and Tolerability of Finafloxacin
NCT01904162
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Pharmacokinetic and Tolerability of Finafloxacin
Interventions
DRUG:
400 mg finafloxacin (2 x 200 mg tablets)
Sponsor
MerLion Pharmaceuticals GmbH